Japan Tissue Engineering Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	-234	147	-725	-494
Depreciation & Amortization	158	134	131	124
Loss (Gain) From Sale of Assets	10	130	-	-
Other Operating Activities	-27	-3	-2	-1
Change in Accounts Receivable	14	-32	-79	325
Change in Inventory	46	9	-50	16
Change in Accounts Payable	-4	-23	14	-114
Change in Other Net Operating Assets	-111	-88	89	-81
Operating Cash Flow	-148	274	-622	-225
Capital Expenditures	-76	-196	-149	-103
Sale (Purchase) of Intangibles	-17	-77	-26	-14
Investment in Securities	-150	-100	1,300	-
Other Investing Activities	11	131	-1	1
Investing Cash Flow	-232	-242	1,124	-116
Miscellaneous Cash Flow Adjustments	-	-1	-1	-1
Net Cash Flow	-380	31	501	-342
Free Cash Flow	-224	78	-771	-328
Free Cash Flow Margin	-9.12%	3.10%	-37.94%	-15.60%
Free Cash Flow Per Share	-5.52	1.92	-18.98	-8.08
Cash Income Tax Paid	27	3	3	3
Levered Free Cash Flow	-185.75	-82.38	-549	-70.25
Unlevered Free Cash Flow	-185.75	-82.38	-549	-70.25
Change in Working Capital	-55	-134	-26	146

Source: S&P Global Market Intelligence. Standard template. Financial Sources.